Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Tata India Pharma & Healthcare Fund · Direct ✕Aditya Birla Sun Life Business Cycle Fund · Direct ✕

Growth of ₹10,000

Basics

Tata India Pharma & Healthcare FundAditya Birla Sun Life Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseTataABSL
NAV₹40.2296₹17.3800
NAV date20 Nov 202619 Nov 2026
History10.9 years4.9 years
Expense ratio1.1%1.5%
Stars★★★★★★★★★★
Growth Score67.5058.40

Returns

Tata India Pharma & Healthcare FundAditya Birla Sun Life Business Cycle Fund
1 month+9.87%+5.46%
3 months+1.12%−0.06%
6 months+7.63%+11.41%
YTD+13.73%+5.98%
1 year+11.82%+5.53%
3 years (CAGR)+18.74%+13.55%
5 years (CAGR)+16.00%—
10 years (CAGR)+15.95%—
Since launch+13.58%+11.61%

Risk

Tata India Pharma & Healthcare FundAditya Birla Sun Life Business Cycle Fund
Volatility15.7%15.3%
Downside volatility10.0%10.4%
Sharpe0.780.46
Sortino1.230.68
Calmar1.120.76
Return / risk1.190.88
Deepest fall−19.84%−17.78%
Days to recover375490
Below its high+0.00%−1.75%

Against benchmark

Tata India Pharma & Healthcare FundAditya Birla Sun Life Business Cycle Fund
Alpha−2.76%+1.91%
Beta1.000.92
R²90.2%92.8%
Up capture91.7%102.6%
Down capture101.4%94.4%
Tracking error4.9%4.3%
Information ratio−0.570.34
Treynor0.110.07

Consistency

Tata India Pharma & Healthcare FundAditya Birla Sun Life Business Cycle Fund
Best 1-year+76.35%+41.47%
Middle 1-year+8.85%+10.16%
Worst 1-year−17.32%−6.80%
1-year periods with a loss29.0%6.8%
Middle 3-year+21.13%+14.52%
Positive months63.9%66.7%
Best day+3.34%+3.90%
Worst day−3.09%−5.64%
Worst 5% day−1.35%−1.39%
Positive days55.4%55.1%
NAVs a year247247

SIP of ₹10,000 a month

Tata India Pharma & Healthcare FundAditya Birla Sun Life Business Cycle Fund
5-year XIRR+18.07%—
5-year value₹9,50,065—
3-year XIRR+13.31%+9.19%
1-year XIRR+18.41%+12.24%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth